Kindred Biosciences, Inc. KIN
$ 9.25
0.11%
Kindred Biosciences, Inc. Balance Sheet 2011-2024 | KIN
Annual Balance Sheet Kindred Biosciences, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
7.99 M | 59 M | -56.3 M | -34.8 M | -6.69 M | -20 M | -13 M | -65.3 M | -938 K | - |
Long Term Debt |
18.5 M | 19.3 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
21.4 M | 21.9 M | 94 K | 115 K | 29 K | 40 K | 44 K | - | 987 K | - |
Total Current Liabilities |
6.9 M | 10.2 M | 15.2 M | 6.03 M | 3.87 M | 3.21 M | 2.85 M | 2.21 M | 70.3 K | - |
Total Liabilities |
28.3 M | 32.1 M | 15.3 M | 6.14 M | 3.9 M | 3.25 M | 2.9 M | 2.21 M | 1.06 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-245 M | -223 M | -162 M | -112 M | -81.1 M | -58.6 M | -31.5 M | -4.33 M | -120 K | - |
Total Assets |
95.8 M | 114 M | 106 M | 90.8 M | 61.6 M | 79.6 M | 102 M | 65.5 M | 938 K | - |
All numbers in USD currency